سعر ساكروفير 100مجم/5مل 5 امبولات 2024

Intravenous iron (iron sucrose) 100 mg/5 ml ampoules, box of 5, by Amoun (Egypt), for iron-deficiency anaemia.

• Treatment of iron-deficiency anaemia in patients with chronic kidney disease (US-approved indication)Population: Adults and children 2 years and older with CKDDailyMed (U.S. National Library of Medicine)

• Most common (>=2%, adults): diarrhoea, nausea, vomiting, headache, dizziness, hypotension, pruritus, pain in extremity, arthralgia, back pain, muscle cramp, injection site reactions, chest pain, peripheral oedema.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to iron sucrose (Venofer).International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Serious, sometimes fatal hypersensitivity/anaphylactic-type reactions; monitor for at least 30 minutes after administration and give only where resuscitation facilities are immediately available.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• May cause clinically significant hypotension related to rate and total dose; risk of iron overload with excessive therapy.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Published studies after the first trimester have not shown adverse maternal or fetal outcomes; first-trimester data are insufficient; untreated IDA and severe maternal hypersensitivity reactions carry risks.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)
• Iron sucrose is present in human milk; published reports after 100-300 mg IV have not reported adverse reactions in breastfed infants.International label, equivalent formulation · DailyMed (U.S. National Library of Medicine)

• Iron sucrose: After IV administration the complex dissociates into iron and sucrose; iron is transported bound to transferrin to erythroid precursors and incorporated into haemoglobin (US Venofer label 12.1).